Proposed Data Collection Submitted for Public Comment and Recommendations, 29450-29451 [2020-10410]
Download as PDF
<![CDATA[
jbell on DSKJLSW7X2PROD with NOTICES
29450
Federal Register / Vol. 85, No. 95 / Friday, May 15, 2020 / Notices
inspection facilities to the extent
practicable and develop stand-alone
Federal facilities for the proposed bus
inspection facilities where necessary. As
a result of the revised proposed action,
GSA has revised the approach to NEPA
documentation. GSA has prepared a
separate Draft Environmental
Assessment (EA) and will prepare a
Finding of No Significant Impact
(FONSI), if appropriate, to analyze the
potential impacts from the proposed
construction of the bus inspection
facility at the San Ysidro LPOE in
California. Two alternatives were
analyzed to include: (1) New ‘‘Basic’’
Facility Buildout; (2) No Build Action.
Regarding the proposed truck inspection
facilities and other bus inspection
facilities previously identified at the
other LPOEs, GSA is negotiating
agreements with state operated
inspection facilities for possible colocated facilities, which will determine
what type of NEPA documentation will
be prepared for those proposed actions.
GSA is also advising the public that
the Draft EA prepared for the
construction of a standalone FMCSA
Bus Inspection Facility at the San
Ysidro LPOE in San Diego, California is
available for public comment.
The Draft EA is being prepared to
comply with the National
Environmental Policy Act (NEPA) of
1969, as amended (42 U.S. Code [U.S.C.]
4321), as implemented by Council on
Environmental Quality (CEQ)
regulations (40 Code of Federal
Regulations [CFR] 1500–1508), and
policies of the GSA as the lead federal
agency. The EA process provides steps
and procedures to evaluate the potential
social, economic, and environmental
impacts for the construction of the
proposed FMCSA Bus Inspection
Facility at the San Ysidro LPOE while
providing an opportunity for local, state,
or federal agencies to provide input
and/or comment through scoping,
public information meetings, and/or a
public hearing. The social, economic,
and environmental considerations are
evaluated and measured, as defined in
the CEQ regulations, by their magnitude
of impacts.
The bus inspection station allows for
FMCSA to conduct proper inspection of
buses entering the United States from
Mexico. FMCSA is required to conduct
a sufficient number of meaningful
vehicle safety inspections and to
accommodate vehicles placed out of
service as a result of said inspections.
The current bus inspection operations at
the San Ysidro LPOE lacks the proper
infrastructure for bus inspections and is
not adequate to maintain regular
inspections. Therefore, the LPOE does
VerDate Sep<11>2014
17:09 May 14, 2020
Jkt 250001
not address safety needs for the
travelling public nor FMCSA staff, nor
capacity needs identified in future
traffic projections at the LPOE. The lack
of dedicated bus inspection
infrastructure exposes FMCSA to safety
concerns while conducting inspections
and is not in conformance with current
FMCSA safety standards. GSA proposes
to construct a new FMCSA Bus
Inspection facility on a federally owned
1.5-acre parcel located north of the
existing LPOE
A public scoping meeting on the
project was held on June 18, 2019.
Comments received during the meeting
were considered by GSA in this Draft
EA. The finding, which is based on the
Draft EA, reflects the GSA’s
determination that construction of the
proposed facility will not have a
significant impact on the quality of the
human or natural environment.
Jared Bradley,
Director, Portfolio Management Division,
Pacific Rim Region, Public Buildings Service.
[FR Doc. 2020–10426 Filed 5–14–20; 8:45 am]
BILLING CODE 6820–YF–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–20–20MZ; Docket No. CDC–2020–
0043]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled ‘‘Emerging Infections Program
(EIP) Tracking of SARS–CoV–2
Infections among Healthcare
Personnel’’. Through this project, EIP
staff will collect data to: (1) Determine
the extent of COVID–19 among HCP
working in U.S. healthcare facilities; (2)
describe characteristics of HCP exposed
to or infected with SARS–CoV–2,
SUMMARY:
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
including clinical activities and
personal protective equipment use; and
(3) compare exposures and other
characteristics of HCP cases and
exposed HCP that do not become cases
to identify risk factors or protective
factors for COVID–19.
DATES: CDC must receive written
comments on or before July 14, 2020.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2020–
0043 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger, of
the Information Collection Review
Office, Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
E:\FR\FM\15MYN1.SGM
15MYN1
29451
Federal Register / Vol. 85, No. 95 / Friday, May 15, 2020 / Notices
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Emerging Infections Program Tracking
of SARS–CoV–2 Infections among
Healthcare Personnel—New—National
Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
CDC proposes to conduct tracking and
interviews of healthcare personnel
(HCP) with COVID–19 (HCP cases) and
HCP exposed to COVID–19 patients but
who do not become cases (HCP noncases) to determine the burden of
infections and identify factors
associated with development of COVID–
19 among HCP of healthcare facilities
within catchment areas of CDC’s
Emerging Infection Program’s (EIP) sites,
a network of 10 state health departments
and their local public health and
academic partners. The EIP is currently
approved under OMB Control No. 0920–
0978 (expiration date: 04/30/2022). EIPs
assist in local, state, and national efforts
to prevent, control, and monitor the
public health impact of infectious
diseases. The 10 EIP sites are:
California, Colorado, Connecticut,
Georgia, Maryland, Minnesota, New
Mexico, New York, Oregon and
Tennessee. Up to 10 EIP sites may
participate in this information
collection, depending on resource
availability during the pandemic.
EIP sites that participate in this
project may choose to implement one or
both project options below:
• Option 1: Tracking of SARS–CoV–
2 infections among HCP;
• Option 2: Assessing risk factors for
infections among HCP exposed to
patients with COVID–19 in healthcare
facilities.
EIP site staff will identify a
convenience sample of healthcare
facilities within the EIP catchment
areas. Hospitals and nursing homes are
prioritized for inclusion, but other types
Number of
respondents
Estimated Annualized Burden Hours
Average
burden per
response
(in hours)
Number of
responses per
respondent
Total burden
(in hours)
Type of respondents
Form name
Healthcare Personnel .......................
4,000
1
30/60
2,000
at
Assessment of Healthcare Personnel.
Exposed to or Infected with SARS–
CoV–2.
No form .............................................
50
24
15/60
300
Total ...........................................
...........................................................
........................
........................
........................
2,300
Occupational Health Nurses
Healthcare Facilities.
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–10410 Filed 5–14–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–20–20HP]
Agency Forms Undergoing Paperwork
Reduction Act Review
jbell on DSKJLSW7X2PROD with NOTICES
of facilities may participate. Each EIP
site will seek to identify three or more
facilities to participate.
For option 1, EIP staff will obtain lists
of HCP cases and contact information
from local or state health department
partners or in some cases from a
healthcare facility’s occupational health
department or infection control
program. To minimize burden on
healthcare facilities, EIP staff will
attempt to obtain HCP lists and contact
information from health departments
whenever possible.
For option 2, EIP staff may need to
work directly with a healthcare facility’s
occupational health department or
infection control program to obtain HCP
names and contact information because
this option requires identification and
data collection from HCP non-cases
(HCP who are exposed to COVID–19
patients but who do not develop
infection).
For both options, EIP staff will collect
data from HCP via telephone interviews
or a self-administered electronic case
report form. There are no costs to
respondents other than their time to
participate. The total estimated
annualized burden hours requested for
this collection is 2,300.
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled National
Evaluation of the DP18–1815
Cooperative Agreement Program:
Category B, Cardiovascular Disease
Prevention and Management to the
VerDate Sep<11>2014
17:09 May 14, 2020
Jkt 250001
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on July 5, 2019, to obtain
comments from the public and affected
agencies. CDC did not receive comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
E:\FR\FM\15MYN1.SGM
15MYN1
]]>Agencies
[Federal Register Volume 85, Number 95 (Friday, May 15, 2020)]
[Notices]
[Pages 29450-29451]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-10410]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-20-20MZ; Docket No. CDC-2020-0043]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled ``Emerging Infections Program
(EIP) Tracking of SARS-CoV-2 Infections among Healthcare Personnel''.
Through this project, EIP staff will collect data to: (1) Determine the
extent of COVID-19 among HCP working in U.S. healthcare facilities; (2)
describe characteristics of HCP exposed to or infected with SARS-CoV-2,
including clinical activities and personal protective equipment use;
and (3) compare exposures and other characteristics of HCP cases and
exposed HCP that do not become cases to identify risk factors or
protective factors for COVID-19.
DATES: CDC must receive written comments on or before July 14, 2020.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2020-
0043 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, of the Information
Collection Review Office, Centers for Disease Control and Prevention,
1600 Clifton Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-
7570; Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
[[Page 29451]]
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
Emerging Infections Program Tracking of SARS-CoV-2 Infections among
Healthcare Personnel--New--National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
CDC proposes to conduct tracking and interviews of healthcare
personnel (HCP) with COVID-19 (HCP cases) and HCP exposed to COVID-19
patients but who do not become cases (HCP non-cases) to determine the
burden of infections and identify factors associated with development
of COVID-19 among HCP of healthcare facilities within catchment areas
of CDC's Emerging Infection Program's (EIP) sites, a network of 10
state health departments and their local public health and academic
partners. The EIP is currently approved under OMB Control No. 0920-0978
(expiration date: 04/30/2022). EIPs assist in local, state, and
national efforts to prevent, control, and monitor the public health
impact of infectious diseases. The 10 EIP sites are: California,
Colorado, Connecticut, Georgia, Maryland, Minnesota, New Mexico, New
York, Oregon and Tennessee. Up to 10 EIP sites may participate in this
information collection, depending on resource availability during the
pandemic.
EIP sites that participate in this project may choose to implement
one or both project options below:
Option 1: Tracking of SARS-CoV-2 infections among HCP;
Option 2: Assessing risk factors for infections among HCP
exposed to patients with COVID-19 in healthcare facilities.
EIP site staff will identify a convenience sample of healthcare
facilities within the EIP catchment areas. Hospitals and nursing homes
are prioritized for inclusion, but other types of facilities may
participate. Each EIP site will seek to identify three or more
facilities to participate.
For option 1, EIP staff will obtain lists of HCP cases and contact
information from local or state health department partners or in some
cases from a healthcare facility's occupational health department or
infection control program. To minimize burden on healthcare facilities,
EIP staff will attempt to obtain HCP lists and contact information from
health departments whenever possible.
For option 2, EIP staff may need to work directly with a healthcare
facility's occupational health department or infection control program
to obtain HCP names and contact information because this option
requires identification and data collection from HCP non-cases (HCP who
are exposed to COVID-19 patients but who do not develop infection).
For both options, EIP staff will collect data from HCP via
telephone interviews or a self-administered electronic case report
form. There are no costs to respondents other than their time to
participate. The total estimated annualized burden hours requested for
this collection is 2,300.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondents Form name respondents responses per response (in (in hours)
respondent hours)
----------------------------------------------------------------------------------------------------------------
Healthcare Personnel.......... Assessment of 4,000 1 30/60 2,000
Healthcare
Personnel.
Exposed to or
Infected with
SARS-CoV-2.
Occupational Health Nurses at No form......... 50 24 15/60 300
Healthcare Facilities.
---------------------------------------------------------------------------------
Total..................... ................ .............. .............. .............. 2,300
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2020-10410 Filed 5-14-20; 8:45 am]
BILLING CODE 4163-18-P
